Esketamine nasal Spray's Long-Term safety under the microscope
NCT ID NCT04829318
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study looked at the long-term safety of esketamine nasal spray (a fast-acting antidepressant) when used together with standard antidepressants in 183 people with treatment-resistant depression. Participants had already completed 32 weeks of esketamine treatment and continued for up to 104 more weeks. The main goal was to track side effects, including serious events and those of special interest like sedation or suicidal thoughts.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Esketamine nasal spray
- What this could lead to
- If successful, this could show that long-term esketamine is safe and tolerable for people with hard-to-treat depression, supporting its continued use.
- What could go wrong
- This is a safety extension study, not designed to prove effectiveness. Side effects like sedation, dissociation, or abuse potential are possible. Results may not apply to all depression patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSIVE DISORDER, MAJOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
A Shine S R O
Pilsen, 31200, Czechia
-
AD71 s.r.o.
Prague, 109 00, Czechia
-
Anima
Alken, 3570, Belgium
-
Bugat Pal Korhaz
Gyöngyös, 3200, Hungary
-
C I A P Centro de investigacion y Asistencia en Psiquiatria
Rosario, 2000, Argentina
-
CEN Consultorios Especializados en Neurociencias
Córdoba, 5000FJF, Argentina
-
Cape Town Clinical Research Centre
Cape Town, 7530, South Africa
-
Centre for Mental Health Prof.N.Shipkovenski EOOD
Sofia, 1377, Bulgaria
-
Centrum Badan Klinicznych PI House sp z o o
Gdansk, 80 546, Poland
-
Centrum Medyczne Care Clinic Katowice
Katowice, 40-568, Poland
-
Chang Gung Memorial Hospital
Taoyuan, 333, Taiwan
-
Changhua Christian Hospital
Changhua, 500, Taiwan
-
Danuvius Klinik Pfaffenhofen Fachklinik für Psychiatrie, Psychotherapie und Psychosomatik
Pfaffenhofen, 85276, Germany
-
Erenkoy Mental Health Hospital
Istanbul, 34736, Turkey (Türkiye)
-
FunDaMos
Buenos Aires, C1405BOA, Argentina
-
Fundacion Lennox
Córdoba, 5000, Argentina
-
G Papanikolaou Hospital of Thessaloniki
Thessaloniki, 57010, Greece
-
Gert Bosch Pretoria South Africa
Pretoria, 0 042, South Africa
-
Hacettepe University Medical Faculty
Ankara, 6100, Turkey (Türkiye)
-
Hospital Pengajar Universiti Putra Malaysia
Serdang, 43400, Malaysia
-
Hospital Raja Permaisuri Bainun
Ipoh, 30990, Malaysia
-
Hospital Tuanku Jaafar
Seremban, 70300, Malaysia
-
Institut Neuropsychiatricke pece
Prague, 18600, Czechia
-
Instituto Medico DAMIC
Córdoba, X5003DCE, Argentina
-
Instituto de Neurociencias San Agustin
La Plata, 1900, Argentina
-
Klinikum Dortmund gGmbH
Dortmund, 44287, Germany
-
Klinische Forschung Hamburg
Hamburg, 20253, Germany
-
Klinische Forschung Schwerin GmbH
Schwerin, 19055, Germany
-
Liv Hospital
Samsun, 55020, Turkey (Türkiye)
-
Mederon LTD at ARTES
Helsinki, 00270, Finland
-
Medical Services Prague S R O
Prague, 16000, Czechia
-
Medizinisches Versorgungszentrum LiO GmbH
Berlin, 12209, Germany
-
Mental Health Center - Rousse
Rousse, 7003, Bulgaria
-
Mlynowamed Specjalistyczny Psychiatryczny Gabinet Lekarski Joanna Lazarczyk
Bialystok, 15-404, Poland
-
Multiprofile Hospital for Active Treatment in Neurology and Psychiatry Sveti Naum
Sofia, 1113, Bulgaria
-
National Taiwan University Hospital
Taipei, 10002, Taiwan
-
NeuropsychiatrieHK, s.r.o.
Hradec Králové, 50002, Czechia
-
Niepubliczny Zaklad Opieki Psychiatrycznej MENTIS
Leszno, 64-100, Poland
-
Oberhavel Kliniken GmbH
Hennigsdorf, 16761, Germany
-
Osrodek Badan Klinicznych CLINSANTE S C
Bydgoszcz, 85 794, Poland
-
Osrodek Badan Klinicznych CLINSANTE S C
Torun, 87 100, Poland
-
Petz Aladar Megyei Oktato Korhaz
Győr, H-9024, Hungary
-
Pharmakologisches Studienzentrum Chemnitz GmbH
Mittweida, 09111, Germany
-
Praxis Dr. med. Kirsten Hahn
Berlin, 13187, Germany
-
Processus Kft
Budapest, 1137, Hungary
-
Psychiatric Clinic 'Agios Charalampos'
Heraklion, 71305, Greece
-
Psychiatricka ambulance Saint Anne s.r.o.
Brno, 60200, Czechia
-
Psychiatricka ambulance, MUDr. Marta Holanova
Brno, 61500, Czechia
-
SPZOZ CSK UM w Lodzi Klinika Zaburzen Afektywnych i Psychotycznych
Lodz, 92-216, Poland
-
Samsung Medical Center
Seoul, 06351, South Korea
-
Sanatorio Prof Leon S Morra S A
Córdoba, X5009BIN, Argentina
-
Severance Hospital Yonsei University Health System
Seoul, 03722, South Korea
-
Somni Bene GmbH
Schwerin, 19053, Germany
-
Specjalistyczny Psychiatryczny Zespol Opieki Zdrowotnej w Lodzi Szpital im. J. Babinskiego
Lodz, 91-229, Poland
-
Taipei Veterans General Hospital
Taipei, 11217, Taiwan
-
University General Hospital of Rio Patras
Pátrai, 26504, Greece
-
University Malaya Medical Centre
Kuala Lumpur, 59100, Malaysia
-
Universitätsklinikum Freiburg - Abteilung für Psychiatrie u. Psychotherapie mit Poliklinik
Freiburg im Breisgau, 79104, Germany
-
Uniwersyteckie Centrum Kliniczne
Gdansk, 80 214, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a single dose of a new drug boost depression relief?
- Can a new pill ease depression without Add-Ons?
- Brain scans could make TMS for depression more precise
- Can brain training help depressed young adults stop ruminating?
- 45,000 students to be tracked: can we predict who will fall into depression?
- New depression pill BI 1569912 put to the test in 225-Person trial